Common use of TO CONSULTING AGREEMENT Clause in Contracts

TO CONSULTING AGREEMENT. This Amendment No. 4 to Consulting Agreement (“Amendment No. 4”) is made as of December 18, 2020, by and between Elicio Therapeutics Inc., formerly operating under the name of Vedantra Pharmaceuticals, Inc., with a principal place of business being Oxx Xxxxxxx Xxxxxx, Building 1400 West, Suite 14303, Cambridge, MA 02139 (“Company”) and Dxxxxxxx Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 90 Xxxxxx Xxxx, Xxxxxxxxxxxx, XX 00000 (“Dxxxxxxx”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Dxxxxxxx and the Company dated as of March 13, 2013 (“Agreement”).

TO CONSULTING AGREEMENT. This Amendment No. 4 5 to Consulting Agreement (“Amendment No. 4”) is made as of December 18February 1, 20202021, by and between Elicio Therapeutics Inc., formerly operating under the name of Vedantra Pharmaceuticals, Inc., with a principal place of business being Oxx Xxxxxxx Xxxxxx, Building 1400 West, Suite 14303, Cambridge, MA 02139 (“Company”) and Dxxxxxxx Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 90 Xxxxxx Xxxx, Xxxxxxxxxxxx, XX 00000 (“Dxxxxxxx”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Dxxxxxxx and the Company dated as of March 13, 2013 (“Agreement”).

TO CONSULTING AGREEMENT. This Amendment No. 4 5 to Consulting Agreement (“Amendment No. 4”) is made as of December 18February 1, 20202021, by and between Elicio Therapeutics Inc., formerly operating under the name of Vedantra Pharmaceuticals, Inc., with a principal place of business being Oxx One Xxxxxxx XxxxxxSquare, Building 1400 West, Suite 14303, CambridgeXxxxxxxxx, MA 02139 XX 00000 (“Company”) and Dxxxxxxx Xxxxxxxx Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 90 00 Xxxxxx Xxxx, Xxxxxxxxxxxx, XX 00000 (“DxxxxxxxXxxxxxxx”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Dxxxxxxx Xxxxxxxx and the Company dated as of March 13, 2013 (“Agreement”).

TO CONSULTING AGREEMENT. This Amendment No. 4 to Consulting Agreement (“Amendment No. 4”) is made as of December 18, 2020, by and between Elicio Therapeutics Inc., formerly operating under the name of Vedantra Pharmaceuticals, Inc., with a principal place of business being Oxx One Xxxxxxx XxxxxxSquare, Building 1400 West, Suite 14303, CambridgeXxxxxxxxx, MA 02139 XX 00000 (“Company”) and Dxxxxxxx Xxxxxxxx Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 90 00 Xxxxxx Xxxx, Xxxxxxxxxxxx, XX 00000 (“DxxxxxxxXxxxxxxx”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Dxxxxxxx Xxxxxxxx and the Company dated as of March 13, 2013 (“Agreement”).